Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.

about

Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.

Item

http://www.wikidata.org/entity/Q50031588

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.

@en

Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.

@nl

type

Item

label

Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.

@en

Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.

@nl

prefLabel

Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.

@en

Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.

@nl

P1476

Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.

@en

P2093

Gary L Yau

http://www.w3.org/2001/XMLSchema#string

Jennifer K Sun

http://www.w3.org/2001/XMLSchema#string

Paolo S Silva

http://www.w3.org/2001/XMLSchema#string

Paul G Arrigg

http://www.w3.org/2001/XMLSchema#string

P2860

Retinopathy in diabetes

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

Vitrectomy in the management of diabetic retinopathy.

Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25.

Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study.

Incidence of rhegmatogenous retinal detachment after vitrectomy in eyes of diabetic patients.

Long-term trends in intraocular pressure after pars plana vitrectomy.

Four-port bimanual vitrectomy in fibrovascular membrane removal.

Ischemic diabetic retinopathy may protect against nuclear sclerotic cataract.

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

P304

126-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/08820538.2017.1353832

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29215958

http://www.w3.org/2001/XMLSchema#string